Clinical Trial Update: A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing G-CHOP to R-CHOP in untreated diffuse large B-cell lymphoma (DLBCL) with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• G-CHOP (G-CHOP)
• R-CHOP

Snippet

Sponsor: Nanjing Yoko Biomedical Co., Ltd. | Conditions: Diffuse Large B-Cell Lymphoma, Unspecified Site | Phase 3 | Status: UNKNOWN